ICI outcomes have been linked to various factors, including tumour mutational burden, hypoxia, interferon-γ, the microbiome, extracellular matrix, molecular and cellular characterization within the tumour microenvironment, and programmed death-ligand 1 (PD-L1) expression [24,26]. This evidence concerns the gene CD274 and neoplasm.